Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
The Editors
Topics & Concepts
HydroxychloroquineChloroquineMultinational corporationAuditCoronavirus disease 2019 (COVID-19)AzithromycinMedicinePolitical scienceBusinessInternal medicinePathologyLawBiologyMalariaMicrobiologyInfectious disease (medical specialty)AccountingAntibioticsDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Pharmacological Receptor Mechanisms and Effects